NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

hey Vubru

its good to see you back here!

Im happy to hear you did not sell.

some problem with data that required going back to individual sites (and covid impacts)

from what they told us (if Im correct) they went back to determine which patients were IDH-mutated. But now it seems that according to Senti that won't play any part in the publication so that could not have held up the publication.

wanting to wait until FDA formalized guidance on external controls

yes that could have been something they may have waited for, but the Lancet article already covered that. Now that has been determined hopefully there is not something next they have come up with to delay the publication. Perhaps LG's poodles must first win the all-American beauty pageant competition before they can publish?

If they submitted along the optimal publication timeline I had suggested, they would have had this published somewhere by now even under a worst case scenario (e.g., sending to 3 different journals).

Thats what I am saying here as well. Mid-November DI told some poster that the article is in peer review. A peer review would at maximum take 6 weeks. That would have landed the journal 3 weeks ago. What I therefore personally think what the hold up is, is that the peer reviewers are in (fierce) disagreement about something. Hopefully, with the new FDA guidance that has now been cleared up and the peer reviewers opposing have subsided.